4a9k: Difference between revisions
Jump to navigation
Jump to search
m Protected "4a9k" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:4a9k.png|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_4a9k", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_4a9k| PDB=4a9k | SCENE= }} | |||
===BROMODOMAIN OF HUMAN CREBBP WITH N-(4-hydroxyphenyl)acetamide=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_22136404}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 22136404 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_22136404}} | |||
==About this Structure== | |||
[[4a9k]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4A9K OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:022136404</ref><references group="xtra"/> | |||
[[Category: Histone acetyltransferase]] | |||
[[Category: Homo sapiens]] | |||
[[Category: Bamborough, P.]] | |||
[[Category: Chung, C W.]] | |||
[[Category: Epigenetic reader]] | |||
[[Category: Histone]] | |||
[[Category: Inhibitor]] | |||
[[Category: Signaling protein]] |
Revision as of 09:18, 11 January 2012
BROMODOMAIN OF HUMAN CREBBP WITH N-(4-hydroxyphenyl)acetamideBROMODOMAIN OF HUMAN CREBBP WITH N-(4-hydroxyphenyl)acetamide
Template:ABSTRACT PUBMED 22136404
About this StructureAbout this Structure
4a9k is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Chung CW, Dean TW, Woolven JM, Bamborough P. Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery. J Med Chem. 2011 Dec 5. PMID:22136404 doi:10.1021/jm201320w